Developing and applying clinically useful approaches to identify individuals with familial hypercholesterolemia in the UK
Familial hypercholesterolemia (FH) meets internationally agreed criteria for screening, and systematic national screening programs should, therefore, be initiated. Cascade testing (to screen at-risk relatives) of known index cases with FH (using a combination of mutation information and lipid levels...
Autors principals: | Humphries, SE, Neil, H |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2010
|
Ítems similars
-
Possibilities of lipid clinics in identifying patients with familial hypercholesterolemia
per: Z. F. Kim, et al.
Publicat: (2023-03-01) -
Risk of fatal stroke in patients with treated familial hypercholesterolemia: a prospective registry study.
per: Huxley, R, et al.
Publicat: (2003) -
Clinical Significance of Screening for Familial Hypercholesterolemia in Patients with Hypercholesterolemia
per: LI Yuan, MA Hongyang, LI Biao, YUE Anna, SHAO Yaqing, SUN Kangyun
Publicat: (2024-12-01) -
IN APPLICABILITY OF THE CARDIOVASCULAR RISK PREDICTOR "SCORE" TO PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (FH)
per: Descamps, O, et al.
Publicat: (2010) -
Unraveling the genetic background of individuals with a clinical familial hypercholesterolemia phenotype
per: Ana Margarida Medeiros, et al.
Publicat: (2024-02-01)